Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Directive 2011/62/EU | Statement: [Directive 2001/83/EC, amendedBy, Directive 2011/62/EU]

Target entity: Directive 2011/62/EU
Context triple: [Directive 2001/83/EC, amendedBy, Directive 2011/62/EU]

• A. Directive 2007/47/EC
  Directive 2007/47/EC is a European Union legislative act that updated and strengthened the regulatory framework for medical devices, active implantable medical devices, and in vitro diagnostic medical devices to improve safety and harmonization across member states.
• B. Directive 2010/53/EU
  Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
• C. Directive 2007/60/EC
  Directive 2007/60/EC is a European Union law that establishes a framework for assessing and managing flood risks to reduce adverse consequences for human health, the environment, cultural heritage, and economic activity.
• D. Directive 2014/65/EU
  Directive 2014/65/EU is a key European Union legislative act that overhauls and strengthens the regulatory framework for investment services and financial markets, commonly known as MiFID II.
• E. Directive 2010/84/EU
  Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: Directive 2011/62/EU
Target entity description: Directive 2011/62/EU is a European Union law aimed at preventing the entry of falsified medicines into the legal supply chain by strengthening controls and safety features for medicinal products.

• A. Directive 2007/47/EC
  Directive 2007/47/EC is a European Union legislative act that updated and strengthened the regulatory framework for medical devices, active implantable medical devices, and in vitro diagnostic medical devices to improve safety and harmonization across member states.
• B. Directive 2010/53/EU
  Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
• C. Directive 2007/60/EC
  Directive 2007/60/EC is a European Union law that establishes a framework for assessing and managing flood risks to reduce adverse consequences for human health, the environment, cultural heritage, and economic activity.
• D. Directive 2014/65/EU
  Directive 2014/65/EU is a key European Union legislative act that overhauls and strengthens the regulatory framework for investment services and financial markets, commonly known as MiFID II.
• E. Directive 2010/84/EU
  Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
• F. None of above. chosen